Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 12,617 | 0 | 0 | 0 | 0 |
| Gross Profit | 12,617 | N/A | N/A | N/A | N/A |
| Operating Expenses | 94,048 | 61,410 | 52,932 | 65,008 | 22,535 |
| Operating Income | -81,431 | -61,410 | -52,932 | -65,008 | -22,535 |
| Other Income | 395 | 948 | 952 | 202 | 121 |
| Pre-tax Income | -81,036 | -60,461 | -51,980 | -64,806 | -22,414 |
| Net Income Continuous | -81,036 | -60,461 | -51,980 | -64,806 | -22,414 |
| Net Income | $-81,036 | $-60,461 | $-51,980 | $-64,806 | $-22,414 |
| EPS Basic Total Ops | -1.39 | -1.54 | -2.11 | -3.35 | -2.28 |
| EPS Basic Continuous Ops | -1.39 | -1.54 | -2.11 | -3.35 | -2.28 |
| EPS Diluted Total Ops | -1.39 | -1.54 | -2.11 | -3.35 | -2.28 |
| EPS Diluted Continuous Ops | -1.39 | -1.54 | -2.11 | -3.35 | -2.28 |
| EPS Diluted Before Non-Recurring Items | -1.39 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-81,124 | $-61,155 | $-52,790 | $-64,927 | $-22,479 |